Factors modifying contrast media induced fibrillation

Area of Science:

• Cardiology
• Pharmacology
• Medical Imaging

Background:

• Ventricular fibrillation is a critical risk associated with contrast media administration.
• Understanding factors influencing contrast media-induced ventricular fibrillation is crucial for patient safety.

Purpose of the Study:

• To investigate the impact of specific contrast media components and pre-treatment conditions on the induction of ventricular fibrillation in a canine model.
• To determine the role of calcium binding additives and physiological pre-conditioning in contrast media-induced arrhythmogenicity.

Main Methods:

• Anesthetized dogs were subjected to right coronary artery injections of meglumine/sodium diatrizoate at a controlled rate (0.4 ml/s).
• Contact time until the onset of fibrillation was the primary measured parameter.
• Experimental groups included variations in contrast media composition (with/without calcium chelators) and pre-treatment protocols (ouabain, induced infarction, prior resuscitation).

Main Results:

• Contrast media containing calcium chelators significantly reduced the contact time required to induce fibrillation compared to those without.
• Pre-treatment with ouabain, induction of sub-acute infarction, and prior fibrillation/resuscitation all increased the contact time for fibrillation.
• These findings indicate that calcium binding additives enhance arrhythmogenic potential, while certain pre-conditioning factors appear protective.

Conclusions:

• Calcium-binding additives in contrast media increase the risk of inducing ventricular fibrillation.
• Pre-treatment with cardiac glycosides, the presence of stable infarcts, or a history of fibrillation and resuscitation do not appear to elevate the risk.
• These results have implications for the formulation of safer contrast agents and patient risk stratification.